课题基金 / 基金详情

CELLULAR ASPECTS OF OPIATE BINDING TO HUMAN LEUKOCYTES

CELLULAR ASPECTS OF OPIATE BINDING TO HUMAN LEUKOCYTES
阿片与人类白细胞结合的细胞方面
批准号:
3210919
负责人:
JOHN J MADDEN
金额:
$19.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-30 至 1993-08-31

项目摘要

项目成果

JOHN J MADDEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The immunomodulatory actions of opiates have been implicated as significant cofactors in the immune deficiencies of opiate addicts and their vulnerability to opportunistic infections, including AIDS. To date, no clear explanation of the mechanism for the immunomodulation has emerged although binding sites for naloxone, B-endorphin, met5-enkephalin and bremazocine have been reported to exist on lymphoid cell membranes. These binding sites are significantly different in ligand specificity and avidity from the opiate receptors of the central nervous system (CNS). To investigate the mechanism of lymphocyte/opiate interactions, three general methodologies will be employed. First, because nonactivated cells lack binding sites for such immunomodulators as morphine, human peripheral T lymphocytes will be activated to cell division with general mitogens or receptor specific agents to see if activation stimulates the presence of binding sites for morphine and naloxone. Second, the location, nature and specificity of a high affinity, naloxone reversible binding site will be studied on lymphocyte subcellular fractions obtained by centrifugation and characterized by specific enzyme and opiate binding assays, Third, the ability of T lymphocytes to take up morphine will be studied to see whether a pathway of internalization followed by binding provides the explanation for the failure to detect membrane surface binding. These three methodologies will be used to define a binding site (receptor) for morphine to parallel its naloxone reversible immunomodulatory properties. Once evidence of morphine contact is defined in terms of mitogen activated versus nonactivated cells, surface binding versus uptake, and the subcellular location of maximal binding, then the specificity and avidity of this interaction can be assessed by pharmacologic methods using ligands of known receptor specificity in the CNS. These experiments are important because no data currently exist to explain the mechanism of morphine's interaction with lymphocytes, yet morphine is the most used drug for demonstrating in vitro immune/opiate effects and the opiate most relevant to street opiate addiction. Finally, knowledge of the ligand specificity would be important in the design of anesthetics without immune effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
9th Conference: Drug Abuse, Immunomodulation & AIDS
8th Conference: Drug Abuse, Immunomodulation and AIDS
  • 批准号:
    6336086
  • 项目类别:
  • 资助金额:
    $2.2万
  • 财政年份:
    2001
  • 负责人:
    JOHN J MADDEN
  • 依托单位:
7TH CONFERENCE: DRUG ABUSE, IMMUNOMODULATION & AIDS
  • 批准号:
    6039811
  • 项目类别:
  • 资助金额:
    $3.0万
  • 财政年份:
    1999
  • 负责人:
    JOHN J MADDEN
  • 依托单位:
6TH CONFERENCE--DRUG ABUSE, IMMUNOMODULATION AND AIDS
  • 批准号:
    2677347
  • 项目类别:
  • 资助金额:
    $3.0万
  • 财政年份:
    1998
  • 负责人:
    JOHN J MADDEN
  • 依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: